Possibility of Radiotherapy-Associated Cardiovascular Side Effects in Breast Cancer Patients by Modern Radiotherapy Techniques

Kuhnt, Thomas; Friese, Martin; Janich, Martin A.; Gerlach, Reinhard; Pelz, Tanja; Haensgen, G.

doi:10.1111/j.1524-4741.2006.00378.x

Cited by 2 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Referring to the findings of Gyenes et al, who investigated on 100 left-sided breast cancer patients treated with standard irradiation, 5.7% of the entire heart received doses of ≥ 25 Gy [2]. Their final results point out that the amount of cardiac volume involved in the treatment fields are linked to long-term cardiac mortality and were recently discussed by Kuhnt [5]. In our study, we found a significant heart dose reduction using the inspiratory-controlled radiotherapy.…”

Section: Discussionsupporting

confidence: 61%

Postoperative Irradiation of Left-Sided Breast Cancer Patients and Cardiac Toxicity

Stranzl

Zurl

2008

Strahlenther Onkol

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 61%

Postoperative Irradiation of Left-Sided Breast Cancer Patients and Cardiac Toxicity

Stranzl

Zurl

2008

Strahlenther Onkol

View full text Add to dashboard Cite

show abstract

Radiation-Induced Heart Disease: An Under-Recognized Entity?

Davis

Witteles

2014

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Radiation-induced heart disease (RIHD) represents a spectrum of cardiovascular disease in patients who have undergone mediastinal, thoracic, or breast radiotherapy (RT). RIHD may involve any cardiac structure and is a major cause of morbidity and mortality in cancer survivors. While large cohort studies have demonstrated that symptomatic RIHD is a common late finding in this population, the incidence of asymptomatic disease is likely to be even higher. Long-term follow-up with regular screening for RIHD plays an important role in the management of cancer survivors who have undergone RT. Aggressive modification of traditional cardiovascular risk factors such as hypertension, dyslipidemia, and cigarette smoking is essential in patients at risk for RIHD, as these have been shown to potentiate the risks of radiation. In patients with symptomatic RIHD, medical and/or percutaneous therapies are often preferable to surgical interventions in view of the increased surgical risk associated with radiation damage to surrounding tissues. Percutaneous revascularization should generally be favored over surgical revascularization. Transcatheter valve replacements have not been widely used in this population but may offer an alternative to high-risk surgical valve procedures. Pericardiectomy is usually associated with extremely poor short-term and long-term outcomes in patients with RIHD and should be avoided in most cases. Heart transplantation is also higher risk in patients with RIHD than in patients with other etiologies of heart failure, but may be considered in young patients without other comorbidities.

show abstract

Possibility of Radiotherapy-Associated Cardiovascular Side Effects in Breast Cancer Patients by Modern Radiotherapy Techniques

Cited by 2 publications

References 13 publications

Postoperative Irradiation of Left-Sided Breast Cancer Patients and Cardiac Toxicity

Postoperative Irradiation of Left-Sided Breast Cancer Patients and Cardiac Toxicity

Radiation-Induced Heart Disease: An Under-Recognized Entity?

Contact Info

Product

Resources

About